Abstract
Current knowledge of Epstein-Barr virus (EBV)-specific T-cell responses in the cerebrospinal fluid (CSF) of patients with EBV-related lymphoproliferative disease (EBV-LPD) in the central nervous system (CNS) is very limited. Here, we present two recipients of hematopoietic stem cell transplants with EBV-LPD in the CNS. EBV-specific CD8(+) T lymphocytes were detected in CSF and peripheral blood using major histocompatibility complex (MHC) class I multimers loaded with EBV-derived peptides. The appearance of EBV-specific CD8(+) T cells in CSF and blood correlated with neurological improvement and disappearance of EBV-LPD. These observations suggest a role for EBV-specific CD8(+) T cells in the control of EBV-LPD in the CNS.
MeSH terms
-
Aged
-
CD8 Antigens / metabolism
-
Central Nervous System Neoplasms / cerebrospinal fluid
-
Central Nervous System Neoplasms / surgery
-
Central Nervous System Neoplasms / virology*
-
Epstein-Barr Virus Infections / cerebrospinal fluid
-
Epstein-Barr Virus Infections / etiology*
-
Epstein-Barr Virus Infections / virology
-
Female
-
Flow Cytometry / methods
-
Hematopoietic Stem Cell Transplantation / adverse effects*
-
Hematopoietic Stem Cell Transplantation / methods
-
Herpesvirus 4, Human / isolation & purification*
-
Humans
-
Lymphoma / cerebrospinal fluid
-
Lymphoma / surgery
-
Lymphoma / virology*
-
Male
-
Middle Aged
-
Nuclear Proteins / metabolism
-
T-Lymphocytes / cytology
-
T-Lymphocytes / immunology
-
T-Lymphocytes / virology*
-
Time Factors
-
Trans-Activators / metabolism
Substances
-
CD8 Antigens
-
MHC class II transactivator protein
-
Nuclear Proteins
-
Trans-Activators